How long should we allow metformin to remain the bogeyman in CKD? Should MALA scare us from ever letting our patients benefit from metformin? Join us as we discuss some rare prospective data on metformin in moderate to severe CKD.
#KidneyWkBingo is back!
The NephJC poster tours return for another run at #KidneyWk
Details of the #NephJC tweetup. 2019 edition
NephJC needs your help. Time to open your wallet and help keep the lights on at NephJC HQ. Also score some pretty fly NephJC fleece, hats and tote bags. (Yeah, we know that there has never been a “fly” tote bag. Work with us.
The NephJC Kidneys return for the fourth year. Time for #NephTwitter to nominate their favs.